clinicaltrials.gov ghk-cu – Y&P Labs GHK-Cu (100mg) Research Peptide |

Until FDA publishes one, pharmacies and clinics should not present speculation as a current exemption

Semaglutide and tirzepatide are incretin peptides that act on entirely different receptors to influence appetite, insulin secretion, and energy balance

ClinicalTrials.gov Registry search for 'SLU-PP-332' confirming no registered or completed human trials

I could only find one reference to excessive Vitamin B12 being linked to blood clotting, on a website belonging to what looks like a private Vietnamese hospital chain

AOD-9604 Fat-burning peptide derived from growth hormone without GH-related risks

Cell 11 , 775789 (2006)